New Phosphatidylserine Patent Could Take Ingredient Beyond Cognitive Support and into Sports
The patent describes the oral administration of PS to maintain healthy testosterone levels, especially in men experiencing decreased levels due to age, exercise, or hypogonadism
As a result of a partnership to study the role of phosphatidylserine (PS) to influence cortisol levels and help maintain healthy testosterone levels and promote healthy aging in exercising and non-exercising men, ingredients firm Chemi Nutra (White Bear Lake, MN) and consultant Increnovo (Milwaukee) have gained a new patent that could see PS’s usage expand beyond cognitive health and into sports nutrition.
The new patent, “Methods using phosphatidylserine, lysophosphatidylserine, and/or salts thereof to increase testosterone levels” (US Patent No. 8,124,594), describes the oral administration of PS to maintain healthy testosterone levels, especially in men experiencing decreased levels due to age, exercise, or hypogonadism (when sex glands decrease hormone production).
According to Scott Hagerman, president of Chemi Nutra, the new patent could also expand focus on PS as an ingredient for sports performance and bodily maintenance. “There has been a lot of research in recent years involving PS in the sports performance realm-looking at cortisol, stress and immune health, muscle soreness reduction and recovery, and improvements in weightlifting, running, and golf. This exciting new discovery will open additional doors for the use of PS in healthy aging, strength training, and body composition management, in men.”
“I am confident that PS will now move beyond its well-known cognitive enhancing health benefits and into this new area of use, as people become aware of these newest hormone related attributes,” he added.
“For the first time, it is now proven that short-term supplementation with a moderate dose of PS not only prevents a stress induced increase in cortisol concentrations, PS additionally can naturally benefit impaired testosterone levels,” added Dr. Martin Purpura, managing member of Increnovo. “These new findings, protected by this recently granted patent, will open new markets for Chemi Nutra’s branded PS, SerinAidPS, for PS-based antiaging and sports nutrition nutritional supplements.”
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.
